comparemela.com

Latest Breaking News On - கேத்தரின் ஒட்தோ - Page 1 : comparemela.com

Updated guideline for heart valve disease spotlights less invasive treatments

 E-Mail DALLAS and WASHINGTON, Dec. 17, 2020 Options to treat heart valve disease are expanding, allowing patients to avoid surgery when possible, according to a new joint clinical practice guideline from the American College of Cardiology and the American Heart Association. The new 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease published today in the AHA s flagship journal Circulation and in the Journal of the American College of Cardiology. About half of all people ages 65 and older have some form of valvular heart disease. If left undiagnosed or untreated in a timely fashion, valvular heart disease can become more severe and can ultimately lead to heart failure and death. Valvular heart disease can affect one or more heart valves - the structures responsible for regulating blood flow to and from the heart. The heart has four chambers for circulating blood into the heart and out to the lungs and the body, and each chamber is separated b

New Valve Disease Guideline: Rethinking TAVR vs SAVR, MitraClip Indications

email article Transcatheter interventions get more love in updated valvular heart disease guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Patients with severe aortic stenosis who have choices for intervention should be included in shared decision-making that considers the lifetime risks and benefits associated with type of valve and type of approach, according to a class I recommendation in the guideline, published online in That said, when aortic valve replacement is indicated, the surgical approach continues to be recommended for most groups. Notable exceptions are people age 65-80 years for whom shared decision-making is emphasized, and people over 80 years old (or younger patients with short life expectancy) for whom transfemoral transcatheter aortic valve replacement (TAVR) is now recommended.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.